Immunovant
IMVT
$29.39
Share price
-1.04%
Change (1 day)
60.78%
Change (1 year)
Categories
Immunovant (IMVT) - Total assets
Total assets on the balance sheet as of December 2023 : $0.71 B
According to Immunovant's latest financial reports the company's total assets are $0.71 B. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Immunovant - Total assets on balance sheet (from 2019 to 2023)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2023-03-31 | $0.40 B | -21.28% |
| 2022-03-31 | $0.51 B | 24.99% |
| 2021-03-31 | $0.41 B | 277.09% |
| 2020-03-31 | $0.10 B | |
| 2018-12-31 | $0.4 M |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $0.25 B | -64.58% | 🇺🇸 USA |